IsoRay Cash Flow - Quarterly (NYSEMKT:ISR)

Add to My Stocks
$0.53 $0.04 (7.02%) ISR stock closing price Sep 19, 2018 (Closing)

The IsoRay cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about IsoRay profits and IsoRay debt. IsoRay had cash and cash equivalents of $10.13M at beginning of the quarter and $2.36M at quarter end of 2018 Q3. IsoRay cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. IsoRay has a negative cash and cash equivalents change of $-3.56M.

View and download details of IsoRay cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jul - Jun2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.35M-0.49M-0.24M--0.39M-0.18M----
Cash From (used in) Discontinued Operations----------
Other Adjustments Net--------0.24M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.23M-0.15M-0.05M-0.54M-0.29M-0.23M-0.14M-0.47M-0.25M-0.03M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments---0.26M2.18M-0.08M-0.05M-0.02M9.24M3.36M-2.61M
Other Cash Inflow (Outflow) from Investment Activities----0.12M-0.15M-0.15M-0.15M-0.01M--0.01M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions-0.01M-0.01M--0.01M-0.01M-0.01M--0.01M-0.01M-0.01M
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year10.13M5.22M7.68M2.89M2.67M2.11M1.67M2.99M4.82M9.35M
Cash & Equivalents at Year End2.36M2.95M3.95M5.93M5.1M6.66M8.45M10.13M5.69M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

IsoRay stock comparison chart provides an easy way to compare the stock price with peers along with details of IsoRay stock price history.
The statement of cash flows can be categorized into the following main sections:

  • IsoRay has cash of $2.36M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the IsoRay stock price.
  • Cash Flow from operating activities: IsoRay reported a negative operating cash flow of $-4.26M till 2018 Q3 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $- for ISR stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for IsoRay. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For IsoRay Cash Flow

Quarterly Cash Flow Statements For IsoRay, Inc. Peers

Biomerica cash flow, Elekta cash flow, VIVOS INC cash flow, RENEURON GP PLC cash flow